Doripenem Use in Pediatrics aâ‚¬“ Learning from Pharmacokinetic Data of Other Carbapenems

Patrick GROVE; Tsz-Yin SO

Makale detayları

Doripenem Use in Pediatrics aâ‚¬“ Learning from Pharmacokinetic Data of Other Carbapenems

Yazarlar:

Patrick GROVE | Tsz-Yin SO

Yayıncı:

Bilal YILDIZ

Dergi:

Journal of Pediatric Sciences 2010 Vol.2 Issue 1

Belge Tipi:

Makale

Yayın Tarihi:

3/2010

Belge Dili:

İngilizce

Document ID (Org No.):

2000743709

Sıklık:

İki Yıllık

eISSN:

1309-1247

Özet:

 

In 2005, doripenem, the newest carbapenem on the market, was developed by a pharmaceutical company in Japan, and it was recently approved by the United States (US) Federal Drug Administration (FDA) to be used in the adult population.  Doripenem is a broad spectrum antimicrobial agent that can be used in many different infections ranging from pneumonia to abdominal infections.  Even though doripenem has shown to be safe and efficacious in adults, it lacks pharmacokinetic and safety information in the pediatric population.  However, by looking at the pediatric pharmacokinetic data of other carbapenems and a recent multicenter study of doripenem in patients between the age of 3 months and 18 years of age, clinicians can gain a better understanding of how to dose this antimicrobial agent in infants, children, and adolescents.

Makale detayları

Doripenem Use in Pediatrics aâ‚¬“ Learning from Pharmacokinetic Data of Other Carbapenems

Yazarlar: Patrick GROVE | Tsz-Yin SO

Yayıncı: Bilal YILDIZ

Dergi: Journal of Pediatric Sciences 2010 Vol.2 Issue 1

Belge Tipi: Makale

Yayın Tarihi: 3/2010

Belge Dili: İngilizce

Document ID (Org No.): 2000743709

Sıklık: İki Yıllık

eISSN: 1309-1247

Sayı

Yazarlar:

Patrick GROVE | Tsz-Yin SO

Yayıncı:

Bilal YILDIZ

Dergi:

Journal of Pediatric Sciences 2010 Vol.2 Issue 1

Belge Tipi:

Makale

Yayın Tarihi:

3/2010

Belge Dili:

İngilizce

Document ID (Org No.):

2000743709

Sıklık:

İki Yıllık

eISSN:

1309-1247